Unfilled prescriptions of medicare beneficiaries: Prevalence, reasons, and types of medicines prescribed

Journal of Managed Care Pharmacy

Volumn 14, Issue 6, 2008, Pages 553-560

  Kennedy, Jae ^a   Tuleu, Iulia ^b   Mackay, Katherine ^c  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b BEAUMONT HOSPITAL   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTACID AGENT; ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTINEOPLASTIC AGENT; ANTIRHEUMATIC AGENT; ANXIOLYTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; BRONCHODILATING AGENT; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; HEMATOLOGIC AGENT; HORMONE DERIVATIVE; HYPNOTIC AGENT; MUSCLE RELAXANT AGENT; NARCOTIC ANALGESIC AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; PROTON PUMP INHIBITOR; PSYCHOTROPIC AGENT; RENIN INHIBITOR; UNINDEXED DRUG;

ARTHRITIS; ARTICLE; ASTHMA; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CAUCASIAN; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLUSTER ANALYSIS; COMORBIDITY; COMPUTER PROGRAM; CONSULTATION; DEMOGRAPHY; DIABETES MELLITUS; DRUG CONTRAINDICATION; DRUG COST; EMPHYSEMA; HEALTH INSURANCE; HUMAN; HYPERTENSION; INCOME; MALIGNANT NEOPLASTIC DISEASE; MEDICAID; MEDICARE; MENTAL DISEASE; NEUROLOGIC DISEASE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHARMACEUTICAL CARE; PHYSICIAN; PRESCRIPTION; PREVALENCE; RACE DIFFERENCE; SELF REPORT; SEX DIFFERENCE; SOCIAL SECURITY; STROKE; TELEPHONE;

EID: 51349156689     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2008.14.6.553     Document Type: Article

References (49)

1. World Health Organization. Adherence to Long-Term Therapies. Evidence for Action. Geneva: WHO; 2003.
2. Sherman FT. Medication nonadherence: a national epidemic among America's seniors. Geriatrics. 2007;62(4):5-6.
3. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-97.
4. Moxey ED, O'Connor JP, Novielli KD, Teutsch S, Nash DB. Prescription drug use in the elderly: a descriptive analysis. Health Care Financ Rev. 2003; 24(4):127-41.
5. Cubanski J, Voris M, Kitchman M, Neuman T, Potetz L. Medicare Chartbook. Menlo Park: Kaiser Family Foundation; 2005.
6. Masoudi FA, Baillie CA, Wang Y, et al. The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001. Arch Intern Med. 2005;165(18):2069-76.
7. Hauptman PJ, Pressler SJ, Sackner-Bernstein J, Ordronneau P, Udelson JE. Rationale and design of CASPER: compliance and quality of life study comparing once-daily carvedilol CR and twice-daily carvedilol IR in patients with heart failure. Am J Cardiol. 2006;98(7A):60L-66L.
8. Chess D, Krentzman M, Charde J. Creating a wellness program/safety net for the medically complex and frail patient. J Ambul Care Manage. 2007; 30(1):30-38.
9. Kennedy J, Coyne J, Sclar D. Drug affordability and prescription noncompliance in the United States: 1997-2002. Clin Ther. 2004;26(4):607-14.
10. Kirking DM, Lee JA, Ellis JJ, Briesacher B, McKercher PL. Patient-reported underuse of prescription medications: a comparison of nine surveys. Med Care Res Rev. 2006;63(4):427-46.
11. Heisler M, Langa KM, Eby EL, Fendrick AM, Kabeto MU, Piette JD. The health effects of restricting prescription medication use because of cost. Med Care. 2004;42(7):626-34.
12. Steinman MA, Sands LP, Covinsky KE. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med. 2001;16(12):793-99.
13. Mojtabai R, Olfson M. Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Aff. (Millwood). 2003;22(4):220-29.
14. Craig BM, Kreling DH, Mott DA. Do seniors get the medicines prescribed for them? Evidence from the 1996-1999 Medicare Current Beneficiary Survey. Health Aff. (Millwood). 2003;22(3):175-82.
15. Neuman P, Strollo MK, Guterman S, et al. Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors. Health Aff. (Millwood). 2007;26(5):w630-43.
16. Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: findings from a 2003 national survey. Health Aff. (Millwood). 2005; (suppl)Web exclusives: w155-w166.
17. Klein D, Turvey C, Wallace R, Elders who delay medication because of cost: health insurance, demographic, health, and financial correlates. Gerontologist. 2004;44(6):779-87.
18. Kennedy J, Erb C. Prescription noncompliance due to cost among adults with disabilities in the United States. Am J Public Health. 2002;92(7):1120-24.
19. Cunningham PJ. Affording Prescription Drugs: Not Just a Problem for the Elderly. Washington DC: Center for Studying Health System Change; 2002.
20. Soumerai SB, Pierre-Jacques M, Zhang F, et al. Cost-related medication nonadherence among elderly and disabled Medicare beneficiaries: a national survey 1 year before the Medicare drug benefit. Arch Intern Med. 2006; 166(17):1829-35.
21. Briesacher B, Limcangco R, Gaskin D. Racial and ethnic disparities in prescription coverage and medication use. Health Care Financ Rev. 2003; 25(2):63-76.
22. Madden JM, Graves AJ, Zhang F, et al. Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA. 2008,299(16):1922-28.23 Bambauer KZ, Safran DG, Ross-Degnan D, et al. Depression and cost-related medication nonadherence in Medicare beneficiaries. Arch Gen Psychiatry. 2007;64(5):602-08.
23. Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med. 2007;22(6):864-71.
24. Wilson IB, Schoen, C, Neuman P, et al. Physician-patient communication about prescription medication nonadherence: a 50-state study of America's seniors. J Gen Intern Med. 2007;22(1):6-12.
25. Piette JD, Heisler M, Krein S, Kerr EA. The role of patient-physician trust in moderating medication nonadherence due to cost pressures. Arch Intern Med. 2005;165(15):1749-55.
26. Piette JD, Heisler M, Wagner TH. Cost-related medication underuse: do patients with chronic illnesses tell their doctors? Arch Intern Med. 2004;164(16):1749-55.
27. Vik SA, Hogan DB, Patten SB, Johnson JA, Romonko-Slack L, Maxwell CJ. Medication nonadherence and subsequent risk of hospitalisation and mortality among older adults. Drugs Aging. 2006;23(4):345-56.
28. Shalansky SJ, Levy AR. Effect of number of medications on cardiovascular therapy adherence. Ann Pharmacother. 2002;36(10):1532-39.
29. Chesney M. Adherence to HAART regimens. AIDS Patient Care STDS. 2003;17(4):169-77.
30. Johnson FR, Ozdemir S, Manjunath R, Hauber AB, Burch SP, Thompson TR. Factors that affect adherence to bipolar disorder treatments: a stated-preference approach. Med Care. 2007;45(6):545-52.
31. Sullivan PS, Campsmith ML, Nakamura GV, Begley EB, Schulden J, Nakashima AK. Patient, and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy. PLoS ONE. 2007; 2(6):e552.
32. Andersson K, Melander A, Svensson C, Lind O, Nilsson JL. Repeat prescriptions: refill adherence in relation to patient and prescriber characteristics, reimbursement level and type of medication. Eur J Public Health. 2005;15(6):621-26.
33. Piette JD, Heisler M, Horne R, Caleb Alexander G. A conceptually based approach to understanding chronically ill patients' responses to medication cost pressures. Soc Sci Med. 2006;62(4):846-57.
34. Elliott RA, Ross-Degnan D, Adams AS, Safran DG, Soumerai SB. Strategies for coping in a complex world: adherence behavior among older adults with chronic illness. J Gen Intern Med. 2007;22(6):805-10.
35. Gemmill MC, Thomson S, Mossialos E. What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries. Int J Equity Health. 2008;7(1):12.
36. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA. 2007;298(1):61-69.
37. Fairman KA. The future of prescription drug cost-sharing: real progress or dropped opportunity? J Manag Care Pharm. 2008;14(1):70-82. Available at: www.amcp.org/data/jmcp/jMCPMaga_janFeb%2008_070-082.pdf.
38. Fairman KA, Motheral BR, Henderson RR. Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization and costs. Clin Ther. 2003;25(12):3147-61; discussion 3144-46.
39. Motheral B, Fairman KA. Effect of three-tier prescription copay on pharmaceutical and other medical utilization. Med Care. 2001; 39(12):1293-1304.
40. Soumerai SB, McLaughlin TJ, Ross-Degnan D, Casteris CS, Bollini P. Effects of a limit on Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med. 1994;331(10):650-55.
41. Soumerai SB, Avorn J, Ross-Degnan D, Gortmaker S. Payment restrictions for prescription drugs under Medicaid: Effects on therapy, cost and equity. N Engl J Med. 1987;317(9):550-56.
42. Taira DA, Iwane KA, Chung RS. Prescription drugs: elderly enrollee reports of financial access, receipt of free samples, and discussion of generic equivalents related to type of coverage. Am J Manag Care. 2003;9(4):305-12.
43. Heisler M, Wagner TH, Piette JD. Clinician identification of chronically ill patients who have problems paying for prescription medications. Am J Med. 2004;116(11):753-58.
44. Centers for Medicare & Medicaid Services. 2004 MCBS Access to Care Survey Codebook. Availabke at: www.cms.hhs.gov/MCBS/Downloads/ A04%20Ric%203.pdf. Accessed July 20, 2008.
45. Shah B, Barnewell B, Bieler G. SUDAAN User's Manual. Research Triangle Park, NC: Research Triangle Institute; 1997.
46. Drug Facts and Comparisons Publishing Group. Drug Facts and Comparisons. St. Louis: Wolters Kluwer Health; 2007.
47. Poisal JA. Reporting of drug expenditures in the MCBS. Health Care Financ Rev. 2003;25(2):23-36.
48. Urquhart J. Role of patient compliance in clinical pharmacokinetics. A review of recent research. Clin Pharmacokinet. 1994;27(3):202-15.
49. Evans C, Crawford B. Patient self-reports in pharmacoeconomic studies: their use and impact on study validity. Pharmacoeconomics. 1999; 15(3):241-56.